Presented on November 26, 2018
Authors:
Ramesh V. Nathan, MD, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Richard L Hengel, MD – Atlanta ID Group, Atlanta, GA
Andrew H Krinsky, MD – Infectious Diseases Associates, Sarasota, FL
Thomas K Sleweon, MD – ID Specialists of Indiana, Highland, IN
Alfred E. Bacon, III, MD – Infectious Disease Associates, PA, Newark, DE
K. Dale Hooker, PharmD – Healix Infusion Therapy, Inc., Knoxville, TN
Claudia P Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX
Kimberly Couch, PharmD, MA, FIDSA, FASHP – Healix Infusion Therapy, Inc, Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX